Overcoming Challenges of Ovarian Cancer Stem Cells: Novel Therapeutic Approaches

被引:37
作者
Aguilar-Gallardo, Cristobal [2 ]
Cecilia Rutledge, Emily [2 ]
Martinez-Arroyo, Ana M. [2 ]
Jose Hidalgo, Juan [3 ]
Domingo, Santiago [3 ]
Simon, Carlos [1 ,2 ]
机构
[1] Univ Valencia, Fdn IVI, Inst Univ IVI, E-46012 Valencia, Spain
[2] Prince Felipe Res Ctr CIPF, Valencia Node Spanish Stem Cell Bank, Valencia, Spain
[3] Univ Hosp La Fe, Valencia, Spain
关键词
Ovarian cancer stem cells; Microenvironment; New therapeutic approaches; ACTIVATED-RECEPTOR-GAMMA; HEPATOCELLULAR-CARCINOMA CELLS; EPITHELIAL OVARIAN; PANCREATIC-CANCER; INITIATING CELLS; PROSPECTIVE IDENTIFICATION; PROGNOSTIC MARKER; DRUG-RESISTANCE; DNA-REPAIR; STAGE-III;
D O I
10.1007/s12015-011-9344-5
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Understanding the genetic and molecular mechanisms of ovarian cancer has been the focus of research efforts working toward the greater goal of improving cancer therapy for patients with residual disease after initial treatment with conventional surgery and neoadjuvant chemotherapy. The focus of this review will be centered on new therapeutic strategies based on Cancer Stem Cells studies of chemoresistant subpopulations, the prevention of metastasis, and individualized therapy in order to find the most successful combination of treatments to effectively treat human ovarian cancer. We reviewed recent literature (1993-2011) of novel treatment approaches to ovarian cancer stem cells. As the focus of ovarian cancer investigation has centered on the cancer stem cell model and the complexities that it presents in the development of effective treatments, the future of treating ovarian cancer lies in utilizing individualized treatment systems that include enhancing existing treatments, aiming for novel therapy targets, managing the plasticity of stem cells to induce cellular differentiation, and regulating oncogenic signaling pathways.
引用
收藏
页码:994 / 1010
页数:17
相关论文
共 174 条
[1]   THY1 expression is associated with tumor suppression of human ovarian cancer [J].
Abeysinghe, HR ;
Cao, Q ;
Xu, J ;
Pollock, S ;
Veyberman, Y ;
Guckert, NL ;
Keng, P ;
Wang, N .
CANCER GENETICS AND CYTOGENETICS, 2003, 143 (02) :125-132
[2]   Expression of CD44S and CD44v5 is more common in stage III than in stage I serous ovarian carcinomas [J].
Afify, AM ;
Ferguson, AW ;
Davila, RM ;
Werness, BA .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2001, 9 (04) :309-314
[3]   Distribution of Gefitinib to the Brain Is Limited by P-glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2)-Mediated Active Efflux [J].
Agarwal, Sagar ;
Sane, Ramola ;
Gallardo, Jose L. ;
Ohlfest, John R. ;
Elmquist, William F. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (01) :147-155
[4]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[5]   Self-renewal and solid tumor stem cells [J].
Al-Hajj, M ;
Clarke, MF .
ONCOGENE, 2004, 23 (43) :7274-7282
[6]   Molecular phenotyping of human ovarian cancer stem cells unravel the mechanisms for repair and chemo-resistance [J].
Alvero, Ayesha B. ;
Chen, Rui ;
Fu, Han-Hsuan ;
Montagna, Michele ;
Schwartz, Peter E. ;
Rutherford, Thomas ;
Silasi, Dan-Arin ;
Steffensen, Karina D. ;
Waldstrom, Marianne ;
Visintin, Irene ;
Mor, Gil .
CELL CYCLE, 2009, 8 (01) :158-166
[7]   Functional and molecular characterisation of mammary side population cells [J].
Alvi, Azra J. ;
Clayton, Helen ;
Joshi, Chirag ;
Enver, Tariq ;
Ashworth, Alan ;
Vivanco, Maria d M. ;
Dale, Trevor C. ;
Smalley, Matthew J. .
BREAST CANCER RESEARCH, 2002, 5 (01)
[8]   EZH2-mediated epigenetic repression of DNA repair in promoting breast tumor initiating cells [J].
Andri Stefansson, Olafur ;
Esteller, Manel .
BREAST CANCER RESEARCH, 2011, 13 (03)
[9]   Overexpression of CD133 Promotes Drug Resistance in C6 Glioma Cells [J].
Angelastro, James M. ;
Lame, Michael W. .
MOLECULAR CANCER RESEARCH, 2010, 8 (08) :1105-1115
[10]  
[Anonymous], Public health